ch 5-8 Flashcards
catecholamines
hormones made by adrenal glands
monoamines
transmitters that possess one amine group
biogenic amines
compounds made by living organisms
adrenergic
adrenaline/ epinephrine (EPI)
noradrenergic
noradrenaline/norepinephrine (NE)
EPI and NE are secreted by…
adrenal medulla
dopaminergic
dopamine (DA)
synthesis of dopamine/norepinehrine
tyrosine –> L- DOPA –> dopamine –> norepinephrine
enzymes required for synthesis (DA, NE)
tyrosine hydroxylase (TH), aromatic amino acid decarboxylase (AACD)
for NE, needs dopamine-β-hydroxylase (DBH) too
rate-limiting enzyme (DA,NE)
determines overall rate of formation because it is the slowest (e.g. TH)
TH inhibition and stimulation
high catecholamine levels inhibit TH (don’t need more), rate of cell firing stimulates TH (more synthesis due to more enzyme activity)
release of catecholamines
synaptic vesicles, important for protection from degrading enzymes and predetermining amount required
vesicular monoamine transporter (VMAT)
responsible for vesicular monoamine reuptake
VMAT1: found in adrenal medulla
VMAT2: found in brain
blocked by reserpin (DA and NE are no longer protected making levels drop)
when do (catecholamine) vesicles open
nerve impulse, but some drugs can cause this effect without needing s nerve impulse (amphetamine, methamphetamine)
release inhibition (catecholamines)
by autoreceptors who either;
1. directly reduce Ca2+ influx needed for exocytosis
2. indirectly reduces Ca2+ by shortening duration of APs entering the terminal
tonic release
DA released in single-spiking mode
phasic release
DA released in burst mode
varicosities
in-passing synpases in which the fibers exhibit repeated swellings
drugs on catecholamine autoreceptors
agonists: stimulate autoreceptors (inhibit release)
antagonists: stimulate release by inhibiting the inhibitory affects of autoreceptors
DA and NE transporters
induce reuptake
DA and NE transporter-blocking drugs
increase transmission in the synapse by not allowing reuptake
breakdown of NE
catechol-O-methyltransferase (COMT) and monoamine oxidase (MOA-A)
breakdown of DA
catechol-O-methyltransferase (COMT) and monoamine oxidase (MOA-B)
metabolites of catecholamines
DA:
- homovanillic acid (HVA)
NE:
- 3-methyl-4-hydroxy-phenylglycol (MHPG) in brain
- vanillymandelic acid in PNS
2 cell groups in midbrain
A1-A7= NE pathways
A8-A16= DA pathways
DA pathway function
from dorsal striatum to substantia nigra facilitates voluntary mvmt
DA pathway lesions
- behavioral dysfunction
- sensory neglect
- motivational deficits
- motor impairment
dopamine deficient mice (DD mice)
- still can produce NE
- lacked DA whole life
- dopaminergic neurons werent damaged, just couldnt produce DA
- all symptoms of lacking DA were fixed momentarily with L-DOPA injection
5 subtypes of DA receptors
- metabotropic (interact with G protein and second messengers
D1 and D2 are most common
D1 and D5 are similar
D2,D3,D4 are similar
D2 receptors
- autoreceptors
- found on pituitary gland that makes prolactin (activation inhibits prolactin)
- can influence K+ channels causing hyperpolarization (inhibiting APs)
- higher affinity for DA than D1
- decrease cAMP
D1
- increases cAMP
- lower affinity for DA
dopamine agonists
apomorphine: agonist for D1 and D2 (classical stimulant)
SKF 38393: agonist for D1 (self grooming in mice)
quinpirole: increase locomotion
dopamine antagonists
suppress exploratory and locomotor behavior
(D2: catalepsy)
NE containing neurons (CNS)
pons and medulla, more specifically in locus coeruleus (A6 cell group)
- provides nearly all NE in the forebrain